BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32790923)

  • 1. Potentiation of antifungal activity of terbinafine by dihydrojasmone and terpinolene against dermatophytes.
    Pinto ÂV; de Oliveira JC; Costa de Medeiros CA; Silva SL; Pereira FO
    Lett Appl Microbiol; 2021 Mar; 72(3):292-298. PubMed ID: 32790923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
    Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
    Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inibitory effects of linalool on fungal pathogenicity of clinical isolates of Microsporum canis and Microsporum gypseum.
    Silva KVS; Lima MIO; Cardoso GN; Santos AS; Silva GS; Pereira FO
    Mycoses; 2017 Jun; 60(6):387-393. PubMed ID: 28198097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.
    Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations.
    Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Papp T; Pesti M; Nagy K; Vágvölgyi C
    Med Mycol; 2014 Feb; 52(2):140-8. PubMed ID: 24004389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal activity of Copaifera langsdorffii Desf oleoresin against dermatophytes.
    Zimmermam-Franco DC; Bolutari EB; Polonini HC; do Carmo AM; Chaves Md; Raposo NR
    Molecules; 2013 Oct; 18(10):12561-70. PubMed ID: 24126374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes.
    Esteban A; Abarca ML; Cabañes FJ
    Med Mycol; 2005 Feb; 43(1):61-6. PubMed ID: 15712608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.
    Shaw D; Singh S; Dogra S; Jayaraman J; Bhat R; Panda S; Chakrabarti A; Anjum N; Chowdappa A; Nagamoti M; Varshney U; Vanam HP; Savio J; Antony M; Rudramurthy SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
    Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
    Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
    Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatophytes growth curve and in vitro susceptibility test: a broth micro-titration method.
    Alió AB; Mendoza M; Zambrano EA; Díaz E; Cavallera E
    Med Mycol; 2005 Jun; 43(4):319-25. PubMed ID: 16110777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
    Simonetti O; Silvestri C; Arzeni D; Cirioni O; Kamysz W; Conte I; Staffolani S; Orsetti E; Morciano A; Castelli P; Scalise A; Kamysz E; Offidani AM; Giacometti A; Barchiesi F
    Mycoses; 2014 Apr; 57(4):233-9. PubMed ID: 26058322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygenated monoterpenes-rich volatile oils as potential antifungal agents for dermatophytes.
    Dias N; Dias MC; Cavaleiro C; Sousa MC; Lima N; Machado M
    Nat Prod Res; 2017 Feb; 31(4):460-464. PubMed ID: 27309978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy.
    Gaurav V; Bhattacharya SN; Sharma N; Datt S; Kumar P; Rai G; Singh PK; Taneja B; Das S
    J Mycol Med; 2021 Mar; 31(1):101087. PubMed ID: 33360137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus, not triamcinolone acetonide, interacts synergistically with itraconazole, terbinafine, bifonazole, and amorolfine against clinical dermatophyte isolates.
    Zhang J; Tan J; Yang L; He Y
    J Mycol Med; 2018 Dec; 28(4):612-616. PubMed ID: 30337054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
    Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
    J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton.
    Arendrup MC; Kahlmeter G; Guinea J; Meletiadis J;
    Clin Microbiol Infect; 2021 Jan; 27(1):55-60. PubMed ID: 32916260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological trends, antifungal drug susceptibility and SQLE point mutations in etiologic species of human dermatophytosis in Al-Diwaneyah, Iraq.
    Mahmood HR; Shams-Ghahfarokhi M; Salehi Z; Razzaghi-Abyaneh M
    Sci Rep; 2024 Jun; 14(1):12669. PubMed ID: 38830918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.